Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Magnetic Resonance Imaging Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy

NCT05704062 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT05704062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05704062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Magnetic Resonance Imaging Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy
Lead sponsor
Corewell Health East
Phase
Observational
Overall status
Recruiting
Start date
March 18, 2010
Completion date
May 31, 2027
Enrollment
135 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer